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Rheology is the study of flow and deformation of 
materials under applied forces. It is primarily 
applicable to liquids but is also applicable to soft-
solids, semi-solids and even solids under 
conditions in which they respond with plastic flow 
[1]. It includes the phenomena of flow of solids, 
liquids and gases; and particularly involves time-
dependent behavior under the influence of 
stresses [2]. The application of rheology extends 
to materials having complex microstructure like 
mud, sludge, suspensions, polymers, silicates, 
body fluids, etc. Rheology describes the behavior 
especially of non-Newtonian fluids wherein 
viscosity changes with change in strain and flow 
velocity [1]. 
Flow is typically measured using shear stress (τ) 
i.e. stress component coplanar with the material 
cross section and strain rate (γ) i.e. deformation 
of material with respect to time. Viscosity (η) is 
calculated as the ratio between sheer stress and 
strain rate [3].  
  
             
                               
 
  
                   
              
 
  
 
 
 
Among body fluids, blood is the best example of 
non-Newtonian fluid. It is a non-homogenous 
fluid suspension having plasma with all its 
dissolved solutes acting as fluid base in which 
formed elements and large protein molecules are 
suspended. 
Hemorheology is very peculiar as the formed 
elements have great flexibility and blood flows in 
compliant vessels. The viscosity is also optimal 
owing to presence of glycocalyx on the surface of 
the blood cells and the endothelium. 
Blood flow almost all the time in most of the 
vascular tree is laminar (streamline) due to many 
factors inherent to components of blood and 
vessel walls. The probability of turbulence 
increases with increase in velocity of blood, 
increase in diameter of vessel and decrease in 
viscosity. Hyperdynamic circulation with 
increased turbulence may physically damage the 
endothelium. On the other hand, sluggishness 
(decrease velocity) of blood flow and increase 
viscosity predisposes to thrombus formation.  
Studies have shown association of various 
disordered states with the changes in physical 
properties of blood [4]. Blood pressure increases 
with increase in blood viscosity [5]. Plasma 
viscosity and RBC aggregation showed 
significant association with cardiovascular 
disease (CVD) [5,6]. Increased hematocrit and 
fibrinogen resulting in increased blood viscosity 
may promote ischemic heart disease (IHD) and 
stroke [7]. Also rheological variables especially 
blood viscosity showed significant correlations 
with conventional cardiovascular risk factors like 
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cigarette smoking, advancing age, hypertension, 
high body mass index and serum total 
cholesterol [8,9,10]. Increased plasma viscosity 
is associated with decreased cognitive ability in 
diabetes possibly by decreasing cerebral blood 
flow [11]. 
Now the question arises – ‘Do rheological 
variables play a causal role in disease?’. 
Rheology is an overlooked component of 
vascular disease [12]. The plausible 
pathophysiological mechanisms by which 
rheological variables might promote CVD are 
atherogenesis, thrombosis or perpetuation of 
ischemia. Increase in blood viscosity increases 
total peripheral resistance thereby raising blood 
pressure. It cannot be told with certainty that the 
association of rheological variables with CVD 
may be a causal relationship or a consequence 
or a mere coincidence and needs larger 
randomized controlled studies for confirmation 
[4]. However, the importance of the rheological 
measures in CVD cannot be ignored as raised 
blood viscosity leading to high vascular shear 
stress contributes to the site specificity of 
atherogenesis, rapid growth of atherosclerotic 
lesions and increases their propensity to rupture 
[13]. Therapeutic intervention in the form of statin 
administration targeting reduction in serum 
lipoproteins significantly reduced both plasma 
and blood viscosity [14]. Drugs like 
dihydropyridine calcium antagonists improve red 
blood cell deformability thereby improving blood 
rheology [15,16]. 
Therefore, enough evidence to show that the 
rheological parameters of blood should also be 
accounted for apart from hemocytometry and 
biochemistry in determining the risk and in the 
prognosis of a disease condition particularly in 
IHD and stroke. Hence, “capturing the fluid 
dynamics of blood” may play a considerable role 
in clinical medicine. 
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